Suppression of metastasis of intravenously-inoculated B16/F10 melanoma cells by the novel ginseng-derived ingredient, gintonin: Involvement of autotaxin inhibition

Hwang,Sung  Hee; Lee,Byung-Hwan; Kim,Hyeon-Joong; Cho,Hee-Jung; Shin,Ho-Chul; Im,Keum-Soon; Choi,Sun-Hye; Shin,Tae-Joon; Lee,Sang-Mok; Nam,Suk  Woo; Kim,Hyoung-Chun; Rhim,Hyewon; Nah,Seung-Yeol

doi:10.3892/ijo.2012.1709

Suppression of metastasis of intravenously-inoculated B16/F10 melanoma cells by the novel ginseng-derived ingredient, gintonin: Involvement of autotaxin inhibition

Authors:
- Sung Hee Hwang
- Byung-Hwan Lee
- Hyeon-Joong Kim
- Hee-Jung Cho
- Ho-Chul Shin
- Keum-Soon Im
- Sun-Hye Choi
- Tae-Joon Shin
- Sang-Mok Lee
- Suk Woo Nam
- Hyoung-Chun Kim
- Hyewon Rhim
- Seung-Yeol Nah
View Affiliations

Affiliations: Department of Physiology and Bio/Molecular Informatics Center, College of Veterinary Medicine, Konkuk University, Seoul, Republic of Korea, Department of Pharmacology and Toxicology, College of Veterinary Medicine, Konkuk University, Seoul, Republic of Korea, Department of Pathology, College of Veterinary Medicine, Konkuk University, Seoul, Republic of Korea, Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea, Neuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National University, Chunchon, Republic of Korea, Life Science Division, Korea Institute of Science and Technology, Seoul, Republic of Korea
Published online on: November 20, 2012 https://doi.org/10.3892/ijo.2012.1709
Pages: 317-326

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ginseng has been used for cancer prevention. However, little is known about its active components and the molecular mechanisms underlying its effects. Recently, we isolated a unique lysophosphatidic acid (LPA) receptor ligand, gintonin. Gintonin contains approximately 9.5% LPA, mainly LPA C18:2. Autotaxin (ATX) is responsible for metastasis by overproducing LPA in cancers. However, LPA, particularly LPA C18:2, is a strong negative feedback ATX inhibitor. It is unknown whether gintonin inhibits ATX activity and whether gintonin‑induced ATX inhibition is coupled with antimetastatic activity. In this study, we examined whether gintonin and LPA C18:2 inhibit ATX activity and metastasis‑related cellular activities in melanoma cells. We found that gintonin and LPA C18:2 inhibited the purified and secreted ATX activity from melanoma cells in a concentration‑dependent manner. Gintonin also inhibited cell migration with a minimal inhibition of cell growth. The oral administration of gintonin or LPA C18:2 inhibited lung metastasis induced by tail‑vein inoculations of melanoma cells. Moreover, the oral administration of gintonin significantly suppressed the tumor growth induced by subcutaneous grafts of melanoma cells. A histological analysis showed that the oral administration of gintonin reduced tumor necrosis, the pleomorphism of tumor cells, tumor cell mitosis and angiogenesis. The present study demonstrates that the gintonin‑induced inhibition of ATX activity may be the molecular basis of ginseng‑induced antimetastatic and antitumor activities.

View Figures

View References

1.	Moolenaar WH: LPA: a novel lipid mediator with diverse biological actions. Trends Cell Biol. 4:213–219. 1994. View Article : Google Scholar : PubMed/NCBI
2.	Mills GB and Moolenaar WH: The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer. 3:582–591. 2003. View Article : Google Scholar : PubMed/NCBI
3.	Chun J, Hla T, Lynch KR, Spiegel S and Moolenaar WH: International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol Rev. 62:579–587. 2010. View Article : Google Scholar : PubMed/NCBI
4.	Kranenburg O and Moolenaar WH: Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists. Oncogene. 20:1540–1546. 2001. View Article : Google Scholar : PubMed/NCBI
5.	Tokumura A, Majima E, Kariya Y, Tominaga K, Kogure K, Yasuda K and Fukuzawa K: Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem. 277:39436–39442. 2002. View Article : Google Scholar : PubMed/NCBI
6.	Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, Yamori T, Mills GB, Inoue K, Aoki J and Arai H: Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol. 158:227–233. 2002. View Article : Google Scholar : PubMed/NCBI
7.	Houben AJ and Moolenaar WH: Autotaxin and LPA receptor signaling in cancer. Cancer Metastasis Rev. 30:557–565. 2011. View Article : Google Scholar : PubMed/NCBI
8.	Stracke ML, Krutzsch HC, Unsworth EJ, Arestad A, Cioce V, Schiffmann E and Liotta LA: Identification, purification and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem. 267:2524–2529. 1992.PubMed/NCBI
9.	van Meeteren LA, Ruurs P, Christodoulou E, Goding JW, Takakusa H, Kikuchi K, Perrakis A, Nagano T and Moolenaar WH: Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate. J Biol Chem. 280:21155–21161. 2005.PubMed/NCBI
10.	Zhang H, Xu X, Gajewiak J, Tsukahara R, Fujiwara Y, Liu J, Fells JI, Perygin D, Parrill AL, Tigyi G and Prestwich GD: Dual activity lysophosphatidic acid receptor pan-antagonist/ autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo. Cancer Res. 69:5441–5449. 2009. View Article : Google Scholar
11.	Uchiyama A, Mukai M, Fujiwara Y, Kobayashi S, Kawai N, Murofushi H, Inoue M, Enoki S, Tanaka Y, Niki T, Kobayashi T, Tigyi G and Murakami-Murofushi K: Inhibition of transcellular tumor cell migration and metastasis by novel carba-derivatives of cyclic phosphatidic acid. Biochim Biophys Acta. 1771:103–112. 2007. View Article : Google Scholar : PubMed/NCBI
12.	Gupte R, Siddam A, Lu Y, Li W, Fujiwara Y, Panupinthu N, Pham TC, Baker DL, Parrill AL, Gotoh M, Murakami- Murofushi K, Kobayashi S, Mills GB, Tigyi G and Miller DD: Synthesis and pharmacological evaluation of the stereoisomers of 3-carba cyclic-phosphatidic acid. Bioorg Med Chem Lett. 20:7525–7528. 2010. View Article : Google Scholar : PubMed/NCBI
13.	Mochizuki M, Yoo YC, Matsuzawa K, Sato K, Saiki I, Tono-oka S, Samukawa K and Azuma I: Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)-and 20(S)-ginsenoside-Rg3, of red ginseng. Biol Pharm Bull. 18:1197–1202. 1995. View Article : Google Scholar : PubMed/NCBI
14.	Pan XY, Guo H, Han J, Hao F, An Y, Xu Y, Xiaokaiti Y, Pan Y and Li XJ: Ginsenoside Rg3 attenuates cell migration via inhibition of aquaporin 1 expression in PC-3M prostate cancer cells. Eur J Pharmacol. 683:27–34. 2012. View Article : Google Scholar : PubMed/NCBI
15.	Pyo MK, Choi SH, Hwang SH, Shin TJ, Lee BH, Lee SM, Lim YH, Kim DH and Nah SY: Novel glycolipoproteins from ginseng. J Ginseng Res. 35:92–103. 2011. View Article : Google Scholar
16.	Hwang SH, Shin TJ, Choi SH, Cho HJ, Lee BH, Pyo MK, Lee JH, Kang J, Kim HJ, Park CW, Shin HC and Nah SY: Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic acids-protein complexes and activates G protein-coupled lysophosphatidic acid receptors with high affinity. Mol Cells. 33:151–162. 2012. View Article : Google Scholar
17.	Liu XW, Sok DE, Yook HS, Sohn CB, Chung YJ and Kim MR: Inhibition of lysophospholipase D activity by unsaturated lysophosphatidic acids or seed extracts containing 1-linoleoyl and 1-oleoyl lysophosphatidic acid. J Agric Food Chem. 55:8717–8722. 2007. View Article : Google Scholar : PubMed/NCBI
18.	Ferguson CG, Bigman CS, Richardson RD, van Meeteren LA, Moolenaar WH and Prestwich GD: Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity. Org Lett. 8:2023–2026. 2006. View Article : Google Scholar : PubMed/NCBI
19.	Poste G, Doll J, Brown AE, Tzeng J and Zeidman I: Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors and individual lung metastases. Cancer Res. 42:2770–2778. 1982.
20.	Gaetano CG, Samadi N, Tomsig JL, Macdonald TL, Lynch KR and Brindley DN: Inhibition of autotaxin production or activity blocks lysophosphatidylcholine-induced migration of human breast cancer and melanoma cells. Mol Carcinog. 48:801–809. 2009. View Article : Google Scholar
21.	Clair T, Lee HY, Liotta LA and Stracke ML: Autotaxin is an exoenzyme possessing 5′-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities. J Biol Chem. 272:996–1001. 1997.PubMed/NCBI
22.	Nam SW, Clair T, Kim YS, McMarlin A, Schiffmann E, Liotta LA and Stracke ML: Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res. 61:6938–6944. 2001.PubMed/NCBI
23.	Moore LD, Isayeva T, Siegal GP and Ponnazhagan S: Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo. Clin Cancer Res. 14:4961–4970. 2008. View Article : Google Scholar : PubMed/NCBI
24.	Hwang SH, Rait A, Pirollo KF, Zhou Q, Yenugonda VM, Chinigo GM, Brown ML and Chang EH: Tumor-targeting nanodelivery enhances the anticancer activity of a novel quinazolinone analogue. Mol Cancer Ther. 7:559–568. 2008. View Article : Google Scholar : PubMed/NCBI
25.	Porstmann T, Ternynck T and Avrameas S: Quantitation of 5-bromo-2-deoxyuridine incorporation into DNA: an enzyme immunoassay for the assessment of the lymphoid cell proliferative response. J Immunol Methods. 82:169–179. 1985. View Article : Google Scholar : PubMed/NCBI
26.	Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D and Boyd MR: Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48:4827–4833. 1988.PubMed/NCBI
27.	Scutti JA, Matsuo AL, Pereira FV, Massaoka MH, Figueiredo CR, Moreira DF, Belizário JE and Travassos LR: Role of SOCS-1 gene on melanoma cell growth and tumor development. Transl Oncol. 4:101–109. 2011. View Article : Google Scholar : PubMed/NCBI
28.	Leberi MF and Efferth T: Molecular principles of cancer invasion and metastasis (Review). Int J Oncol. 34:881–895. 2009.PubMed/NCBI
29.	Deng W, Shuyu E, Tsukahara R, Valentine WJ, Durgam G, Gududuru V, Balazs L, Manickam V, Arsura M, VanMiddlesworth L, Johnson LR, Parrill AL, Miller DD and Tigyi G: The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury. Gastroenterology. 132:1834–1851. 2007. View Article : Google Scholar : PubMed/NCBI
30.	Adachi M, Horiuchi G, Ikematsu N, Tanaka T, Terao J, Satouchi K and Tokumura A: Intragastrically administered lysophosphatidic acids protect against gastric ulcer in rats under water-immersion restraint stress. Dig Dis Sci. 56:2252–2261. 2011. View Article : Google Scholar
31.	Xu X and Prestwich GD: Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three-dimensional lung cancer xenograft model. Cancer. 116:1739–1750. 2010. View Article : Google Scholar : PubMed/NCBI
32.	Gierse J, Thorarensen A, Beltey K, Bradshaw-Pierce E, Cortes-Burgos L, Hall T, Johnston A, Murphy M, Nemirovskiy O, Ogawa S, Pegg L, Pelc M, Prinsen M, Schnute M, Wendling J, Wene S, Weinberg R, Wittwer A, Zweifel B and Masferrer J: A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation. J Pharmacol Exp Ther. 334:310–317. 2010. View Article : Google Scholar : PubMed/NCBI
33.	Albers HM, Dong A, van Meeteren LA, Egan DA, Sunkara M, van Tilburg EW, Schuurman K, van Tellingen O, Morris AJ, Smyth SS, Moolenaar WH and Ovaa H: Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation. Proc Natl Acad Sci USA. 107:7257–7262. 2010. View Article : Google Scholar : PubMed/NCBI
34.	van Meeteren LA, Brinkmann V, Saulnier-Blache JS, Lynch KR and Moolenaar WH: Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D. Cancer Lett. 266:203–208. 2008.PubMed/NCBI